{"id":315508,"date":"2020-01-31T20:00:31","date_gmt":"2020-02-01T04:00:31","guid":{"rendered":"https:\/\/nai500.com\/blog\/2020\/01\/verastem-oncology-announces-dosing-of-first-patient-in-cspcs-chinese-study-evaluating-copiktra\/"},"modified":"2020-01-31T21:50:22","modified_gmt":"2020-02-01T05:50:22","slug":"verastem-%e4%b8%8e%e7%9f%b3%e8%8d%af%e9%9b%86%e5%9b%a2%e5%ae%8c%e6%88%90-copiktra-%e7%9a%84%e4%b8%ad%e5%9b%bd%e9%a6%96%e4%be%8b%e6%82%a3%e8%80%85%e7%bb%99%e8%8d%af","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2020\/01\/verastem-%e4%b8%8e%e7%9f%b3%e8%8d%af%e9%9b%86%e5%9b%a2%e5%ae%8c%e6%88%90-copiktra-%e7%9a%84%e4%b8%ad%e5%9b%bd%e9%a6%96%e4%be%8b%e6%82%a3%e8%80%85%e7%bb%99%e8%8d%af\/","title":{"rendered":"Verastem\u4e0e\u77f3\u836f\u96c6\u56e2\u5b8c\u6210COPIKTRA\u00ae\u7684\u4e2d\u56fd\u9996\u4f8b\u60a3\u8005\u7ed9\u836f"},"content":{"rendered":"<p>Verastem Oncology Inc. (Nasdaq: VSTM)\uff08\u7b80\u79f0\u201cVerastem\u201d\uff09\u662f\u4e00\u5bb6\u751f\u7269\u5236\u836f\u516c\u53f8\uff0c\u81f4\u529b\u4e8e\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u5bfb\u6c42\u6539\u5584\u764c\u75c7\u60a3\u8005\u751f\u5b58\u7387\u548c\u751f\u6d3b\u8d28\u91cf\u7684\u836f\u7269\u3002Verastem\u5408\u4f5c\u4f19\u4f34\u77f3\u836f\u96c6\u56e2\u5236\u836f\u96c6\u56e2\u6709\u9650\u516c\u53f8\uff08HKEx\uff1a1093\uff09\uff08\u201c\u77f3\u836f\u96c6\u56e2\u201d\uff09\u662f\u4e2d\u56fd\u9886\u5148\u7684\u5236\u836f\u516c\u53f8\uff0c\u5df2\u5728\u4e00\u9879\u5173\u952e\u7684\u4e2d\u56fd\u6865\u63a5\u7814\u7a76\u4e2d\u5bf9\u9996\u4f4d\u60a3\u8005\u8fdb\u884c\u7ed9\u836f\uff0c\u8be5\u7814\u7a76\u8bc4\u4f30\u4e86\u590d\u53d1\u6216\u96be\u6cbb\u6027\u6ee4\u6ce1\u6027\u6dcb\u5df4\u7624\u60a3\u8005\u4f7f\u7528COPIKTRA\u00ae\uff08duvelisib\uff09\u7684\u7597\u6548\u3002 COPIKTRA\u662f\u78f7\u9178\u808c\u91873\u6fc0\u9176\uff08PI3K\uff09\u7684\u53e3\u670d\u6291\u5236\u5242\uff0c\u4e5f\u662f\u7f8e\u56fd\u7b2c\u4e00\u4e2a\u6279\u51c6\u7684PI3K-\u03b4\u548cPI3K-\u03b3\u53cc\u91cd\u6291\u5236\u5242\u3002<\/p>\n<p>Verastem\u9996\u5e2d\u6267\u884c\u5b98Brian Stuglik\u8bf4\uff1a\u201c\u6839\u636e\u77f3\u836f\u96c6\u56e2\u5728\u4e2d\u56fd\u6210\u529f\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u80bf\u7624\u4ea7\u54c1\u7684\u826f\u597d\u5f80\u7ee9\uff0c\u6211\u4eec\u5f88\u9ad8\u5174\u4e0e\u77f3\u836f\u96c6\u56e2\u8fdb\u884c\u8fd9\u9879\u8bd5\u9a8c\uff0c\u81f4\u529b\u4e8e\u4e3a\u4e2d\u56fd\u7684\u6ee4\u6ce1\u6027\u6dcb\u5df4\u7624\u60a3\u8005\u63d0\u4f9b\u65b0\u7684\u9009\u62e9\u3002\u8be5\u8bd5\u9a8c\u4e2d\u7684\u9996\u4f4d\u60a3\u8005\u662f\u6211\u4eec\u5c06COPIKTRA\u5e26\u7ed9\u5168\u7403\u60a3\u8005\u7684\u4f7f\u547d\u4e2d\u7684\u5173\u952e\u4e00\u6b65\u3002\u201d<\/p>\n<p>2018\u5e749\u6708\uff0cVerastem\u4e0e\u77f3\u836f\u96c6\u56e2\u7b7e\u7f72\u4e86\u4e00\u9879\u72ec\u5bb6\u8bb8\u53ef\u534f\u8bae\uff0c\u4ee5\u4f9b\u77f3\u836f\u96c6\u56e2\u5f00\u53d1\u548c\u5546\u4e1a\u5316Verastem\u7684COPIKTRA\uff0c\u4ee5\u6cbb\u7597\u4e2d\u56fd\u7684\u6240\u6709\u80bf\u7624\u9002\u5e94\u75c7\u3002\u77f3\u836f\u96c6\u56e2\u7684\u5355\u81c2\u3001\u5f00\u653e\u6807\u7b7e\u3001\u591a\u4e2d\u5fc3\u67a2\u7ebd\u7814\u7a76\u65e8\u5728\u8bc4\u4f30duvelisib\u5bf9\u88ab\u8bca\u65ad\u60a3\u6709\u590d\u53d1\u6027\u6216\u96be\u6cbb\u6027\u6ee4\u6ce1\u6027\u6dcb\u5df4\u7624\u60a3\u8005\u7684\u6297\u80bf\u7624\u6d3b\u6027\u548c\u5b89\u5168\u6027\u3002\u6839\u636eVerastem\u7684DYNAMO 2\u671f\u7814\u7a76\u4e2d\u89c2\u5bdf\u5230\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\uff0c\u8be5\u7814\u7a76\u6709\u671b\u4f5c\u4e3a\u8fc7\u6e21\u7814\u7a76\u3002\u8fd9\u9879\u7814\u7a76\u7684\u7ed3\u679c\u5c06\u6210\u4e3aCOPIKTRA\u5728\u4e2d\u56fd\u6cbb\u7597\u590d\u53d1\u6027\u6216\u96be\u6cbb\u6027\u6ee4\u6ce1\u6027\u6dcb\u5df4\u7624\u7684\u6cd5\u89c4\u4f9d\u636e\u7684\u57fa\u7840\u3002<\/p>\n<p>COPIKTRA\u4e8e2018\u5e749\u6708\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u7684\u6279\u51c6\uff0c\u7528\u4e8e\u81f3\u5c11\u7ecf\u8fc7\u4e24\u6b21\u4ee5\u4e0a\u6cbb\u7597\u7684\u590d\u53d1\u6216\u96be\u6cbb\u6027\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\/\u5c0f\u6dcb\u5df4\u7ec6\u80de\u6dcb\u5df4\u7624\uff08CLL \/ SLL\uff09\u7684\u6210\u4eba\u60a3\u8005\u3002 COPIKTRA\u4e5f\u83b7\u5f97\u4e86\u52a0\u901f\u6279\u51c6\uff0c\u7528\u4e8e\u6cbb\u7597\u60a3\u6709\u590d\u53d1\u6027\u6216\u96be\u6cbb\u6027\u6ee4\u6ce1\u6027\u6dcb\u5df4\u7624\u7684\u6210\u5e74\u60a3\u8005\u3002 \u6ee4\u6ce1\u6027\u6dcb\u5df4\u7624\u7684\u7ee7\u7eed\u6279\u51c6\u53ef\u80fd\u53d6\u51b3\u4e8e\u9a8c\u8bc1\u6027\u8bd5\u9a8c\u4e2d\u5bf9\u4e34\u5e8a\u76ca\u5904\u7684\u9a8c\u8bc1\u548c\u63cf\u8ff0\u3002<\/p>\n<p>COPIKTRA\u662f\u78f7\u9178\u808c\u91873\u6fc0\u9176\uff08PI3K\uff09\u7684\u53e3\u670d\u6291\u5236\u5242\uff0c\u4e5f\u662f\u7f8e\u56fd\u9996\u4e2a\u6279\u51c6\u7684PI3K-delta\u548cPI3K-\u03b3\u53cc\u91cd\u6291\u5236\u5242\uff0cPI3K-delta\u548cPI3K-\u03b3\u662f\u5df2\u77e5\u7684\u4e24\u79cd\u9176\uff0c\u53ef\u5e2e\u52a9\u652f\u6301\u6076\u6027B\u7ec6\u80de\u7684\u751f\u957f\u548c\u5b58\u6d3b\u3002PI3K\u4fe1\u53f7\u4f20\u5bfc\u53ef\u80fd\u5bfc\u81f4\u6076\u6027B\u7ec6\u80de\u589e\u6b96\uff0c\u5e76\u88ab\u8ba4\u4e3a\u5728\u652f\u6301\u6027\u80bf\u7624\u5fae\u73af\u5883\u7684\u5f62\u6210\u548c\u7ef4\u6301\u4e2d\u53d1\u6325\u4f5c\u7528\u3002<\/p>\n<p>\u82f1\u6587\u6765\u6e90\uff1aBiospace<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Verastem Oncology Inc. (Nasdaq: VSTM), (Verastem Oncology or the Company) today announced that its partner CSPC Pharmaceutical Group Limited (HKEx: 1093) (CSPC)<\/p>\n","protected":false},"author":9,"featured_media":315505,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[820,513,455,459],"class_list":["post-315508","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-820","tag-513","tag-455","tag-459","sectors-life-science-zh-hans","locations-china-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/315508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=315508"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/315508\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/315505"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=315508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=315508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=315508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}